Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-011946
Filing Date
2018-05-08
Accepted
2018-05-08 19:25:16
Documents
1
Period of Report
2018-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 28034
  Complete submission text file 0000899243-18-011946.txt   29363
Mailing Address 1351 BRYANT COURT AMBLER PA 19002
Business Address
TERRERI PETER R (Reporting) CIK: 0001238456 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 18816307

Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 510-240-6000
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations